"Allergy and Asthma Associates has established the Food Allergy Center, the first and only one of its kind in Orange County, to focus exclusively on the diagnosis and now treatment of food allergy. We are now offering oral immunotherapy. The purpose of oral immunotherapy (OIT) is to decrease your sensitivity to allergy-causing foods, so that exposure to the offending food (peanut, milk, egg, tree nuts etc.) will result in fewer and less severe symptoms in the event of an accidental exposure."

During the past decade, Allergy & Asthma Associates of Southern California conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allergy & Asthma Associates of Southern California" #1 sponsor was "Aimmune Therapeutics, Inc." with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Sunovion" with 3 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Attenua, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

According to Clinical.Site data, the most researched conditions in "Allergy & Asthma Associates of Southern California" are "Peanut Allergy" (6 trials), "Atopic Dermatitis" (4 trials), "Chronic Cough" (2 trials), "Dermatitis, Atopic" (2 trials) and "Perennial Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Allergy & Asthma Associates of Southern California" in a lesser frequency.

Most popular intervention types in "Allergy & Asthma Associates of Southern California" are "Drug" (14 trials), "Biological" (6 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AR101" (4 trials), "AR101 powder provided in capsules & sachets" (1 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy & Asthma Associates of Southern California" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Allergy & Asthma Associates of Southern California". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Allergy & Asthma Associates of Southern California, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy & Asthma Associates of Southern California, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".